Insiders / Biogen Idec Inc.
Biogen Idec Inc.
Companies
4
First seen
Mar 11, 2015
Last activity
Aug 12, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Sangamo Therapeutics, Inc · SGMO | 17,652,466 | — |
| Sage Therapeutics, Inc. · SAGE | 6,241,473 | — |
| Apellis Pharmaceuticals, Inc. · APLS | 0 | — |
| Reata Pharmaceuticals Inc · RETA | 0 | — |
All securities held
2 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Sage Therapeutics, Inc. | Common stock | 6,241,473 |
| Sangamo Therapeutics, Inc | Common stock | 17,652,466 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Sep 26, 2023 | Sell Open-market sale | SGMO Sangamo Therapeutics, Inc Common Stock | $3.00M | -6.0M -25.37% | 17,652,466 4.26% of shares | medium |
| Aug 29, 2022 | Sell Open-market sale | SGMO Sangamo Therapeutics, Inc Common Stock | $2.13M | -400K -1.66% | 23,752,466 5.73% of shares | medium |
| Dec 23, 2021 | Sell Open-market sale | SGMO Sangamo Therapeutics, Inc |